Apolipoprotein B (APOB)-containing very LDL (VLDL) production, secretion, and clearance by hepatocytes is a central determinant of hepatic and circulating lipid levels. Impairment of any of the aforementioned processes is associated with the development of multiple diseases. Despite the discovery of genes and processes that govern hepatic VLDL metabolism, our understanding of the different mechanistic steps involved is far from complete. An impediment to these studies is the lack of tractable hepatocyte-based systems to interrogate and follow APOB in cells, which the current study addresses.


You can read the full story here!

Share this message

Latest news Medical Biochemistry Amsterdam

By duda-wsm July 9, 2026
At the annual symposium of the Amsterdam institute for Immunology and Infectious diseases (AII), Guillermo Griffith has won the best poster award within the Immunology program. Congrats, Guillermo!!
By duda-wsm July 9, 2026
On June 17th, Amber Meurs successfully defended her PhD thesis “A cycle of trasport and regulation - unveiling the hidden routes of cellular cholesterol transport” at the University of Amsterdam.
Show More